December 20, 2012
Take a moment to look back at the ten most interesting and significant genetic findings of 2012 or at least the ones that drew our attention. In the last 12 months we’ve seen huge strides in genetic research giving us new insight into serious conditions such as Alzheimer’s as well as new treatments for [...]
October 12, 2012
Dave Hinds is a Principal Scientist in Statistical Genetics. 23andMe is passionate about research on a group of rare blood disorders called myeloproliferative neoplasms, or MPNs. Physicians who study these disorders consider them to be blood cancers, though individual prognoses can vary widely — some [...]
October 1, 2012
Ashley Gould, 23andMe's Vice President Corporate Development and Chief Legal Officer We recently topped our goal of enrolling 1,000 people with a group of rare blood disorders known as myeloproliferative neoplasms, or MPNs. As a testament to the passion of the people who’ve enrolled in our MPN Research [...]
September 4, 2012
Dr. Ross Levine Last year 23andMe launched a Myeloproliferative Neoplasms Research Initiative to study this group of rare blood cancers. We are now very close to reaching our goal of enrolling 1,000 patients and are encouraged by what we’ve already learned. We’re also humbled that another star in the [...]
May 29, 2012
By Meghan Mullins Before joining 23andMe, I worked at a more traditional genetic research lab. Like virtually all research centers, we didn’t return genetic results to our research participants. I occasionally thought about what that meant, that I knew more about an anonymous stranger’s DNA than he [...]
May 11, 2012
Cancer is not one disease, but many. Even looking specifically at breast cancer or sarcoma, the more researchers study these diseases, the more they understand that there are many different kinds of breast cancer and sarcoma. This has been one of the most challenging aspects of researching cures for [...]
March 9, 2012
In August of last year, I wrote with hope and excitement about the launch of the 23andMe MPN Research Initiative because my father, Harvey, suffers from myelofibrosis. On March 5, 23andMe scientist Bethann Hromatka posted a SNPWatch report about the association between the JAK2 gene and MPNs. 23andMe [...]
March 7, 2012
Luck is not the word you typically associate with a cancer diagnosis or even a heightened risk of cancer, but some people can see a silver lining even in the darkest storms. Harvey Gould and John Lauerman certainly have. “Some believe that blessings come out of serious adversity,” said Harvey, who [...]
March 5, 2012
Myeloproliferative neoplasms (MPN) have a complicated name but it’s an apt descriptor for the biology underlying this group of rare blood disorders. MPNs result from excessive production of “myeloid” blood cells that originate in the bone marrow, and come in different forms including essential [...]
March 2, 2012
On Monday we kicked off a campaign for Rare Disease Day to raise awareness of research, especially into two rare diseases, myeloproliferative neoplasms (MPN) and sarcoma. We hoped to reach 500 participants in our MPN research initiative and 800 participants in our Sarcoma Community by today, and are happy to [...]
